There is a particular kind of technology leader who is drawn to complexity. Not despite the stakes, but because of them. Kenneth Jensen is one of those people, and we are delighted to welcome him to Liva as our new Chief Product and Technology Officer.
Over the past decade, Kenneth has built and scaled product and engineering organisations across environments where the technology is not optional infrastructure. Pension systems. AI-powered language platforms. Logistics operations. In each case, the work carried real consequences for the people depending on it. That is the thread running through his career, and it is exactly what brought him to Liva.
We asked him a few questions.
In your own words, what is your role?
I'm joining as Chief Product and Technology Officer. In practice, that means I lead everything from what we build to how we build it: product strategy, engineering, platform, data, AI, and ensuring we do all of it safely and compliantly. My job is to ensure the technology we ship genuinely makes a difference for the people using it, and that the team has the help, focus and leadership to do their best work.
What drew you to Liva?
Several things came together. I've spent most of my career in complex, regulated environments where technology has real stakes, and Liva sits squarely in that space. But what really stood out was the team I met throughout the process. There was a clear sense of people who care deeply about what they're building and why. That kind of motivation is hard to fake, and it matters a lot to me when choosing where to put my energy.
What are you most excited to work on?
Bringing strategic clarity so the team can move with more confidence and less noise in a space where technology and human impact are genuinely inseparable. At Liva, AI isn't only a feature, it's a way to reach more people and support them better. Working at that intersection is exactly the kind of challenge I find meaningful.
"A platform like Liva's has the potential to make a real difference to so many people's health and lives. Getting to contribute to that is a privilege I don't take lightly."
We have been building something that requires both clinical rigour and technical ambition in equal measure. Having Kenneth lead that work is exactly the kind of move that makes the next chapter possible.
Welcome, Kenneth.
